Digital Pathology Blog

For my nearly 30 years of working in health care - in some form or another – I’ve repeatedly heard one guiding principle: run lean. What does that mean? Lean methodologies have been applied and adapted across just about every type of industry. Banking, construction, health care, government, manufacturing, engineering, design, back office administration and more. It is not just for the more "industrial" sectors; it can and has been applied across a diverse range of industries. There are lean programs for supply chain, administration, management, product development, manufacturing and others.

Pathologists frequently mention “I consulted on this” or “I sent this case off to a consultant” or “We were consulted about…”. But what does it mean? It is frequently puzzling for clinicians or patients. Does that mean my tissue specimen went to another laboratory? Does that mean slides or images from my case were seen outside the institution? Who gets consulted? Who pays for this?

According to the College of American Pathologists (CAP) 2013 data, approximately 80 percent of the world’s pathologists are based in the United States. This concentration causes an increased need to access, share, and diagnose images remotely.

In nearly every conversation we have with major hospital centers and pathology labs, the question comes up about how to initiate 2^nd opinion pathology referrals from outside the US. Everybody wants to know: how can we work with China…or India…or other areas of the world where pathology is dramatically underserved? Most US expert centers have a healthy referral business, with slides arriving via mail and FedEx daily/weekly. Going digital in pathology would provide the means to increase referral business by streamlining and accelerating the process, from image acquisition to diagnostic report. 

The Affordable Care Act and market changes like baby boomers entering their senior years with a decreasing amount of doctors to care for them are driving a mind-blowing rate of change in healthcare. Medical practices, including pathology, will sink or swim based on how they adapt to the new realities.

It’s interesting to look beyond the U.S. to see how global digital pathology adoption is progressing. After a three month test pilot last year (with more testing over the next ten months), University Hospitals Coventry and Warwickshire NHS Trust has launched a digital pathology system across its facility with the Omnyx Integrated Digital pathology system from GE Healthcare.

Pathologists, particularly forensic pathologists and medical examiners, seem to provoke endless curiosity from Hollywood television writers. The pathology fascination can be seen in shows throughout the years like Quincy ME, Body of Proof, Rizzoli and Isles, and the CSI shows:

When you boil it down to the bones, digital pathology needs to do one thing: make life easier for pathologists. Their role involves supporting physicians and patients across many institutions, geographies and hardware. They need to integrate all they do with their LISs. The end result has to be a better, faster, smarter, and easier to use workflow environment.

Major changes rarely evolve in a linear fashion. It usually comes down to a group of people pushing forward a new model while another group holds on with both hands to the status quo. Then a small group in the middle plays its role as the bridge to both sides.

Maybe not much, but it got us thinking. There has been some buzz lately about medical tourism funneling revenues away from US hospitals to overseas providers that offer popular procedures at lower cost.

The Centers for Disease Control (CDC) estimates that up to 750,000 US residents travel abroad to get care each year, while other sources put the number at closer to a million. The most common procedures sought by US residents in other countries include cosmetic surgery, dentistry, and heart surgery. The impetus for this mini-exodus is the hunt for cheaper medical procedures.